Chin‐Hsien Lin

8.0k total citations · 1 hit paper
206 papers, 5.0k citations indexed

About

Chin‐Hsien Lin is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Chin‐Hsien Lin has authored 206 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Neurology, 60 papers in Molecular Biology and 47 papers in Cellular and Molecular Neuroscience. Recurrent topics in Chin‐Hsien Lin's work include Parkinson's Disease Mechanisms and Treatments (107 papers), Neurological disorders and treatments (37 papers) and Neurological diseases and metabolism (28 papers). Chin‐Hsien Lin is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (107 papers), Neurological disorders and treatments (37 papers) and Neurological diseases and metabolism (28 papers). Chin‐Hsien Lin collaborates with scholars based in Taiwan, United States and China. Chin‐Hsien Lin's co-authors include Ruey‐Meei Wu, Chun‐Hwei Tai, Ming‐Jang Chiu, Meng‐Ling Chen, Jou‐Wei Lin, Chia‐Hsuin Chang, Han‐Lin Chiang, Yi‐Cheng Tai, Cheng‐Ting Chien and Han‐Yi Lin and has published in prestigious journals such as Circulation, Nature Communications and Journal of Neuroscience.

In The Last Decade

Chin‐Hsien Lin

194 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease

2019 346 citations Chin‐Hsien Lin, Chieh‐Chang Chen et al. profile →

Peers

Countries citing papers authored by Chin‐Hsien Lin

Since Specialization

Citations

This map shows the geographic impact of Chin‐Hsien Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chin‐Hsien Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chin‐Hsien Lin more than expected).

Fields of papers citing papers by Chin‐Hsien Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chin‐Hsien Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chin‐Hsien Lin. The network helps show where Chin‐Hsien Lin may publish in the future.

Co-authorship network of co-authors of Chin‐Hsien Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chin‐Hsien Lin. A scholar is included among the top collaborators of Chin‐Hsien Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chin‐Hsien Lin. Chin‐Hsien Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intranasal Mitochondrial Transplantation Restores Mitochondrial Function and Modulates Glial–Neuronal Interactions in a Genetic Parkinson’s Disease Model of UQCRC1 Mutation 2025 ·Cells ·Jui‐Chih Chang, Chin‐Hsien Lin, (unknown), Mei‐Fang Cheng, (unknown), (unknown), (unknown), Chin‐San Liu	1
2	Plasma Glial Fibrillary Acidic Protein Correlates With Brain Metal Burden in Wilson's Disease 2025 ·Annals of Clinical and Translational Neurology ·(unknown), Ya‐Fang Chen, Cheng‐Hsuan Li, (unknown), Ni‐Chung Lee, Yin‐Hsiu Chien, Wuh‐Liang Hwu, Tai‐Chung Tseng, Tung‐Hung Su, (unknown), Huey‐Ling Chen, Chin‐Hsien Lin, Yen‐Hsuan Ni	0
3	Investigating Plasma Metabolomics and Gut Microbiota Changes Associated With Parkinson Disease 2025 ·Neurology ·Chieh‐Chang Chen, (unknown), Ai Huey Tan, (unknown), Shen‐Yang Lim, Eng‐King Tan, Sven Pettersson, Chih‐Cheng Hsu, Jyh‐Ming Liou, (unknown), Chia‐Lang Hsu, Chin‐Hsien Lin	1
4	Practices, Resources and Challenges in Parkinson's Disease Management in Asia: Movement Disorders in Asia Study Group Report 2025 ·Movement Disorders Clinical Practice ·Norlinah Mohamed Ibrahim, (unknown), Priya Jagota, Roongroj Bhidayasiri, Pramod Kumar Pal, Chin‐Hsien Lin, Prashanth Lingappa Kukkle, Taku Hatano, Shen‐Yang Lim, (unknown), Huifang Shang, (unknown), Raymond L. Rosales, Jinyoung Youn, (unknown), Shivam Om Mittal, Azmawati Mohammed Nawi, Yoshikazu Ugawa	0
5	Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice 2024 ·Movement Disorders ·Tiago F. Outeiro, Lorraine V. Kalia, Erwan Bézard, Juan E. Ferrario, Chin‐Hsien Lin, Mohamed Salama, David G. Standaert, (unknown), Ryōsuke Takahashi, Miquel Vila, Brit Mollenhauer, Per Svenningsson	1
6	Formoterol Acting via β2-Adrenoreceptor Restores Mitochondrial Dysfunction Caused by Parkinson’s Disease-Related UQCRC1 Mutation and Improves Mitochondrial Homeostasis Including Dynamic and Transport 2024 ·Biology ·Jui‐Chih Chang, (unknown), (unknown), Ching‐Shan Huang, Chin‐Hsien Lin, (unknown), (unknown), Chin‐San Liu, Chieh‐Sen Chuang	1
7	Isotropic multi-scale neuronal reconstruction from high-ratio expansion microscopy with contrastive unsupervised deep generative models 2023 ·Computer Methods and Programs in Biomedicine ·(unknown), Mengyun Wu, (unknown), (unknown), Ya‐Hui Lin, (unknown), (unknown), (unknown), Kam W. Leong, Wen‐Sung Lai, Ann‐Shyn Chiang, Kuo‐Chuan Wang, Chin‐Hsien Lin, (unknown), Li‐An Chu	2
8	Genetic Movement Disorders Commonly Seen in Asians 2023 ·Movement Disorders Clinical Practice ·Priya Jagota, Shen‐Yang Lim, Pramod Kumar Pal, Jee‐Young Lee, Prashanth Lingappa Kukkle, Shinsuke Fujioka, Huifang Shang, Onanong Phokaewvarangkul, Roongroj Bhidayasiri, Norlinah Mohamed Ibrahim, Yoshikazu Ugawa, (unknown), Beomseok Jeon, Cid Czarina E. Diesta, (unknown), Chin‐Hsien Lin	3
9	Plasma metabolites of aromatic amino acids associate with clinical severity and gut microbiota of Parkinson’s disease 2023 ·npj Parkinson s Disease ·Szu‐Ju Chen, Yujun Wu, Chieh‐Chang Chen, Yu‐Wei Wu, Jyh‐Ming Liou, Ming‐Shiang Wu, Ching‐Hua Kuo, Chin‐Hsien Lin	12
10	Historical and More Common Nongenetic Movement Disorders From Asia 2023 ·Journal of Movement Disorders ·Norlinah Mohamed Ibrahim, Priya Jagota, Pramod Kumar Pal, Roongroj Bhidayasiri, Shen‐Yang Lim, Yoshikazu Ugawa, (unknown), Beomseok Jeon, Shinsuke Fujioka, Jee‐Young Lee, Prashanth Lingappa Kukkle, Huifang Shang, Onanong Phokaewvarangkul, Cid Czarina E. Diesta, (unknown), Chin‐Hsien Lin	1
11	Clinical Characteristics, Genetic Features, and Long-Term Outcome of Wilson’s Disease in a Taiwanese Population: An 11-Year Follow-Up Study 2023 ·Journal of Movement Disorders ·(unknown), (unknown), Ni‐Chung Lee, Yin‐Hsiu Chien, Wuh‐Liang Hwu, Yu‐Hsuan Huang, (unknown), Tai‐Chung Tseng, Tung‐Hung Su, Shiou‐Ru Tzeng, (unknown), Huey‐Ling Chen, Chin‐Hsien Lin, Yen‐Hsuan Ni	4
12	Elevated α-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson’s disease 2022 ·GeroScience ·(unknown), Tzu-Ting Lai, Szu‐Ju Chen, Chin‐Hsien Lin	25
13	Mild Chronic Colitis Triggers Parkinsonism in LRRK2 Mutant Mice Through Activating TNF‐α Pathway 2021 ·Movement Disorders ·Chin‐Hsien Lin, Han‐Yi Lin, (unknown), (unknown), Mei‐Fang Cheng, Chyng‐Yann Shiue, (unknown), (unknown), (unknown), Li‐An Chu, (unknown), Ya‐Hui Lin, Yi‐Cheng Tai, Chia‐Tung Shun, Han‐Mo Chiu, Ming‐Shiang Wu	32
14	Development of Assaying Plasma TDP-43 Utilizing Immunomagnetic Reduction 2020 ·Shieh‐Yueh Yang, (unknown), (unknown), Ming‐Jang Chiu, Ta‐Fu Chen, Chin‐Hsien Lin, (unknown)	2
15	Differences in road-crossing decisions between healthy older adults and patients with Alzheimer's disease 2018 ·Journal of Safety Research ·(unknown), Chin‐Hsien Lin, Yung‐Ching Liu, Yang‐Kun Ou	5
16	HIV-associated parkinsonism reversed with antiretroviral therapy 2014 ·Yu‐Wen Cheng, Chin‐Hsien Lin, Ruey‐Meei Wu	4
17	Foodborne botulinum type E intoxication associated with dried bean curd: first case report in Taiwan. 2011 ·PubMed ·(unknown), Yimei Wang, Chin‐Hsien Lin	2
18	Novel variant Pro143Ala in HTRA2 contributes to Parkinson’s disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria 2011 ·Human Genetics ·Chin‐Hsien Lin, Meng‐Ling Chen, Grace Shiahuy Chen, Chun‐Hwei Tai, Ruey‐Meei Wu	45
19	Protein N-Arginine Methylation in Subcellular Fractions of Lymphoblastoid Cells 2000 ·The Journal of Biochemistry ·Chin‐Hsien Lin, Ming-Li Hsieh, (unknown), (unknown), (unknown), K. Michael Pollard, (unknown)	6
20	Optimization of electroporation conditions for expression of GUS activity in electroporated protoplasts and intact plant cells 1997 ·Plant Physiology and Biochemistry ·Chin‐Hsien Lin, (unknown), Ling Xiao, (unknown), (unknown), James A. Saunders	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact